| Stage | KEX | % of rev | RCL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $922M | 100.00% | $5.6B | 100.00% | RCL ×6.06 |
| Gross profit | $291M | 31.53% | $2.9B | 51.51% | RCL +20.0pp |
| Operating income | $122M | 13.27% | $1.9B | 33.46% | RCL +20.2pp |
| Pre-tax income | $118M | 12.84% | $1.8B | 31.51% | RCL +18.7pp |
| Net income | $90M | 9.74% | $1.7B | 31.03% | RCL +21.3pp |
| Stage | KEX | RCL | Gap · A − B |
|---|---|---|---|
| Revenue | $922M100.00% | $5.6B100.00% | RCL ×6.06 |
| Gross profit | 31.53%$291M | 51.51%$2.9B | RCL +20.0pp |
| Operating income | 13.27%$122M | 33.46%$1.9B | RCL +20.2pp |
| Pre-tax income | 12.84%$118M | 31.51%$1.8B | RCL +18.7pp |
| Net income |
| 9.74%$90M |
| 31.03%$1.7B |
| RCL +21.3pp |
No disclosed counterparties: RCL.
None